EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

Exploratory Comparison of Meld, Meld-Na, and Meld 3.0 Scores for Prognostic Assessment at Diagnosis in Hepatocellular Carcinoma Using Machine Learning Approaches

Pablo Martínez-Blanco, Miguel Suárez, Jorge Mateo, Sergio Gil-Rojas, Natalia Martínez-García, Pilar Blasco, Miguel Torralba, Ana María Torres

Digestive Diseases and Sciences · 2026-10 · 71 (10) · 4743-4755

DOI: 10.1007/s10620-026-10032-6 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 30.05.2026. Verfasst von Pablo Martínez-Blanco und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Cuenca University Hospital, 16002, Cuenca, Spain. Hauptthemen laut MEDLINE: Boosting Machine Learning Algorithms, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatocellular carcinoma (HCC) is the most common primary liver tumor. Despite efforts to mitigate risk factors and implement surveillance programs in high-risk populations, such as screening, these strategies alone appear insufficient to significantly improve prognosis at diagnosis. The identification of novel prognostic factors remains an underdeveloped field that may play a key role in guiding optimal therapeutic decisions from the initial stages of patient management. AIMS: To develop a machine-learning prognostic model to compare the prognostic performance of different MELD-based scores at the time of HCC diagnosis and to assess their relative clinical applicability in comparison with established prognostic staging systems. METHODS: A multicenter retrospective analysis including 219 patients with HCC was performed. For MELD-based score comparisons and model development, 216 patients with complete MELD, MELD-Na, and MELD 3.0 data constituted the analytic cohort. Clinical and diagnostic variables were analyzed using machine-learning approaches. RESULTS: In the analytic cohort, 148 all-cause deaths occurred during follow-up. Among the MELD-derived models, MELD 3.0 showed higher discrimination than MELD and MELD-Na. EXtreme Gradient Boosting (XGB) algorithm achieved the best overall performance and calibration (AUC 0.94, Brier score 0.13, calibration slope 1.02, CITL 0.03). A parsimonious reduced-feature XGB model including TNM stage, MELD 3.0, ECOG-PS, ALP, and AFP retained most of the discriminatory performance of the full model (AUC 0.91). CONCLUSIONS: These findings suggest that updated MELD-based scores, particularly MELD 3.0, may provide complementary prognostic information at the time of HCC diagnosis. The XGB-based model may represent a feasible tool for exploratory prognostic modeling and may support more precise risk stratification and personalized, data-driven therapeutic decisions in patients with HCC. Further validation in larger, prospective cohorts is warranted before clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boosting Machine Learning AlgorithmsCarcinoma, HepatocellularLiver NeoplasmsAgedFemaleHumansMaleMiddle AgedNeoplasm StagingPredictive Learning ModelsPrognosisRetrospective StudiesSeverity of Illness Index

Stichwörter der Autor:innen

Hepatocellular carcinomaMELDMachine learningPrognosisXGBoost

Autor:innen und Institutionen

  • Gastroenterology Department, Cuenca University Hospital, 16002, Cuenca, Spain.
  • Medical Analysis Expert Group, Institute of Technology, Universidad de Castilla-La Mancha, 16071, Cuenca, Spain.
  • Medical Analysis Expert Group, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45071, Toledo, Spain.
  • Medical Analysis Expert Group, Institute of Technology, Universidad de Castilla-La Mancha, 16071, Cuenca, Spain. Jorge.Mateo@uclm.es.
  • Medical Analysis Expert Group, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45071, Toledo, Spain. Jorge.Mateo@uclm.es.
  • Internal Medicine Unit, Guadalajara University Hospital, 19002, Guadalajara, Spain.

Zitieren

APA

Martínez-Blanco, P., Suárez, M., Mateo, J., Gil-Rojas, S., Martínez-García, N., Blasco, P., Torralba, M., & Torres, A. M. (2026). Exploratory Comparison of Meld, Meld-Na, and Meld 3.0 Scores for Prognostic Assessment at Diagnosis in Hepatocellular Carcinoma Using Machine Learning Approaches. Digestive Diseases and Sciences, 71(10), 4743-4755. https://doi.org/10.1007/s10620-026-10032-6

Vancouver

Martínez-Blanco P, Suárez M, Mateo J, Gil-Rojas S, Martínez-García N, Blasco P, et al. Exploratory Comparison of Meld, Meld-Na, and Meld 3.0 Scores for Prognostic Assessment at Diagnosis in Hepatocellular Carcinoma Using Machine Learning Approaches. Digestive Diseases and Sciences. 2026;71(10):4743-4755. doi:10.1007/s10620-026-10032-6

BibTeX
@article{MartnezBlanco2026,
  author = {Martínez-Blanco, Pablo and Suárez, Miguel and Mateo, Jorge and Gil-Rojas, Sergio and Martínez-García, Natalia and Blasco, Pilar and Torralba, Miguel and Torres, Ana María},
  title = {Exploratory Comparison of Meld, Meld-Na, and Meld 3.0 Scores for Prognostic Assessment at Diagnosis in Hepatocellular Carcinoma Using Machine Learning Approaches},
  journal = {Digestive Diseases and Sciences},
  year = {2026},
  volume = {71},
  number = {10},
  pages = {4743--4755},
  doi = {10.1007/s10620-026-10032-6}
}
Kostenlos starten →